Slide

The first intradermal needle-free vaccine against Mycoplasma hyopneumoniae and PCV2, all in one.

Now the M.hyo-PCV2 vaccination process is quick, easy and with the safety of needle-free intradermal administration:

READY-TO-USE
NEEDLE-FREE
INTRADERMAL
SINGLE DOSE

Protection against M.hyo-PCV2 and the loss of productivity that they cause.

Broad protection against PCV2: The first vaccine in the EU with registered efficacy against PCV2 genotypes a , b and d.

The lightest and most precise IoT (Internet of Things) needle-free device, Hipradermic® 3.0.

Our Knowledge

M.hyo, PCV2 and the intradermal route: this is our experts’ hub, where you can find useful information about today’s swine protection culture.

HOW TO PREVENT MYCOPLASMA

Alex Eggen

IMPACT OF PCV2 VACCINATION

Quim Segalés

ADDRESSING M.HYO AND PCV2 VACCINATION

The Experts

Associated Services

The lightest intradermal needle-free device with IoT (Internet of Things) connectivity, for swine vaccination.

An innovative artificial intelligence system to evaluate lung lesions through pictures and link it with farm productivity. Making Enzootic Pneumonia assessment easy, simple and reliable.

Service programme for knowledge of PRRS, M.hyo and PCV2 and their productive and economic effects on the farm, which supports correct decision-making.

Using state-of-the-art technology to provide a broad panel of diagnosis for M.hyo and PCV2.